Amphiregulin-dependant deacetylation of Ku70 promotes BAX inhibition and resistance to gefitinib in non small cell lung cancer

被引：0
|
作者：
Busser, B. [1 ]
Niang, C. [1 ]
Coll, J. L. [1 ]
Favrot, M. [1 ]
Hurbin, A. [1 ]
机构：
[1] CHU Grenoble, Inst Albert Bonniot, INSERM, Dept Biol Integree Cancerol,U578, Grenoble, France
来源：
BULLETIN DU CANCER | 2008年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [21] Gefitinib for the treatment of non-small-cell lung cancer
    Campbell, Lynn
    Blackhall, Fiona
    Thatcher, Nicholas
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (08) : 1343 - 1357
  • [22] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer
    Yusuf, Syed W.
    Kim, Peter
    Durand, Jean-Bernard
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2367 - 2367
  • [23] Gefitinib therapy for non-small cell lung cancer
    Birnbaum A.
    Ready N.
    Current Treatment Options in Oncology, 2005, 6 (1) : 75 - 81
  • [24] TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription
    Weiwei Yuan
    Wei Xu
    Yan Li
    Wei Jiang
    Yue Li
    Qiqing Huang
    Bo Chen
    Shuangshuang Wu
    Yu Wang
    Weiwei Song
    Weihong Zhao
    Jianqing Wu
    Cell Death & Disease, 10
  • [25] Gefitinib for the treatment of non-small-cell lung cancer
    Hida, Toyoaki
    Ogawa, Shizu
    Park, Jang Chul
    Park, Ji Young
    Shimizu, Junichi
    Horio, Yoshitsugu
    Yoshida, Kimihide
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (01) : 17 - 35
  • [26] Spotlight on gefitinib in non-small-cell lung cancer
    Frampton, JE
    Easthope, SE
    AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (02) : 133 - 136
  • [27] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [28] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
  • [29] Gefitinib for non-small-cell lung cancer treatment
    D'Incecco, Armida
    Cappuzzo, Federico
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (06) : 987 - 996
  • [30] TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription
    Yuan, Weiwei
    Xu, Wei
    Li, Yan
    Jiang, Wei
    Li, Yue
    Huang, Qiqing
    Chen, Bo
    Wu, Shuangshuang
    Wang, Yu
    Song, Weiwei
    Zhao, Weihong
    Wu, Jianqing
    CELL DEATH & DISEASE, 2019, 10 (4)
12345